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 BACKGROUND-     
   Cardiovascular disease is the commonest cause of mortality globally, accounting annually for 
nearly 12 million deaths, with coronary artery disease (CAD) being the major contributor. There 
is a steady increase in the prevalence of CAD due to rapid changes in demography and lifestyle 
consequent to economic development. 
Conventional risk factors such as hypertension, diabetes mellitus, and smoking are increased in 
Indians due to urbanization and Western acculturation. Non-conventional factors such as 
hyperinsulinemia, insulin resistance, and lipoprotein(a) (Lp[a]) are determined by genes, and 
their high prevalence among Indians probably explains the precocious nature of CAD that 
typically affects Indians. These multiplicative effects of conventional and emerging risk factors 
appear to provide an explanation for excess burden of CAD among Indians. The increased 
concentration of atherogenic lipoproteins plays an important role in the development of 
atherosclerosis leading to premature myocardial infarction and stroke. Lp(a) is an 
atherothrombogenic lipoprotein that is inherited as a genetic quantitative trait and Is an important 
emerging risk factor for premature coronary heart disease (CHD). 
Lipoprotein(a) has evolved as a genetically-linked risk factor in thrombosis. High levels of Lp(a) 
have been identified within the atherosclerotic plaque and may represent an important link 
between atherogenesis and thrombogenesis. Higher Lp(a) levels are associated with a 2-3-fold 
risk of CAD which increases exponentially with concomitant presence of low HDL cholesterol, 
high total cholesterol/HDL cholesterol ratio or high homocysteine; all of which are common 
among Asian Indians, a race known to bear the burden of premature CAD. 
Hence, the present study is on simultaneous measurement of several lipid biomarkers and 
calculation of lipid tetrad index (LTI). The LTI is derived by multiplying three lipids which are 
directly associated with CAD and dividing the product by high-density lipoprotein (HDL) which 
is inversely associated with CAD.  
                Lipid tetrad index =  Total cholesterol*Triglycerides*Lipoprotein (a) 
                                                               High density lipoprotein 
 
AIMS AND OBJECTIVES 
 
    To compare the serum lipid patterns in “ST Elevation Myocardial Infarction” patients and 
healthy controls and to establish Lipid Tetrad Index as a promising atherogenic index. 
 
 
 
METHODS:- 
SETTING: Coronary Care Unit , Cardiology Department, Govt. Rajaji Hospital, Madurai 
Medical College, Madurai. 
 INCLUSION CRITERIA: Patients admitted with anginal pain and ECG showing ST Elevation 
MI, Elevated Creatine kinase-MB levels.  
EXCLUSION CRITERIA: Patients with/on Diabetes Mellitus, Hypothyroidism, Chronic Renal 
Failure, Nephrotic Syndrome, Hormone Replacement Therapy, Statins and/or Fibrates. 
DESIGN OF STUDY: Observational study. 
PERIOD OF STUDY: 6 Months from February 2018 to July 2018.  
PARTICIPANTS: 100 ST elevation myocardial infarction patients admitted in Coronary Care 
Unit, Govt. Rajaji hospital and 100 age and sex-matched healthy subjects. 100 patients admitted 
in Coronary Care unit with another primary diagnosis are selected based on the 
inclusion/exclusion criteria &100 normal subjects taken. 
 METHOD: Fasting venous samples were collected and sent for lipid profile and lipoprotein(a) 
estimation .Lipid Tetrad Index is calculated using the following formula 
 
                 LTI= TOTAL CHOLESTEROL*TRIGLYCERIDES*LIPOPROTEIN A 
                                             HIGH DENSITY LIPOPROTEIN 
 
 
 RESULTS : 
 In our study,100 cases and controls were included. Age and sex were matched between 
cases and control groups, and there was no significant difference between two groups. 
Sixty percent were males, and 40% were females in both control and study groups. 
 The mean HDL ( 36.62 vs 43.69) is lower in study group compared to control group.. 
  The mean plasma Lp(a) is greater in study group compared to the control group (37.25 
vs 18.73mg/dl ) which is statistically significant.  
 There is no statistically significant gender difference in the mean plasma Lp(a) and LTI 
in the control and study groups. 
   LTI values in study group are greater compared to control group for their respective age 
distribution and is statistically significant (24093.53 vs 5582.09). 
  There is a highly significant positive correlation between the LTI and Lp(a) levels. There 
is a negative correlation between LTI and the HDL which is statistically significant. 
 The mean plasma TC, TGL, VLDL are greater in study group compared to the control 
group.  
 
  The effect of various lipid parameters as well as Lp(a) on the atherogenicity is not 
additive but multiplicative which is well demonstrated by the lipid tetrad index. The 
mean lipid tetrad index of the patients with CAD was significantly higher than the 
patients without CAD. 
 
 
 
CONCLUSION : 
This study on evaluation of LTI in ACS shows that it is a promising atherogenic index in risk 
factor assessment when compared to other lipid parameters. LTI facilitates in early identification 
of individuals with high risk for premature CAD as a result of their genetic predisposition. Since 
no well-established Lp(a) lowering drugs are available at present, there is a need to create 
awareness for early detection and modification of other risk factors in young individuals. Early 
intervention like lipid lowering drugs helps preventing the progression of atherosclerosis and in 
reducing the morbidity and mortality from ACS. 
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